TuisABCL • NASDAQ
add
AbCellera Biologics Inc
Vorige sluiting
$4,87
Dagwisseling
$4,76 - $4,92
Jaarwisseling
$1,89 - $6,52
Markkapitalisasie
1,44 mjd USD
Gemiddelde volume
5,39 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 17,08 m | 133,29% |
Bedryfskoste | 27,46 m | -54,13% |
Netto inkomste | -34,73 m | 5,97% |
Netto winsgrens | -203,27 | 59,69% |
Wins per aandeel | -0,12 | 7,69% |
EBITDA | -44,11 m | 22,51% |
Effektiewe belastingkoers | 4,45% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 553,08 m | -17,49% |
Totale bates | 1,40 mjd | -0,74% |
Totale aanspreeklikheid | 394,98 m | 31,00% |
Totale ekwiteit | 1,01 mjd | — |
Uitstaande aandele | 298,83 m | — |
Prys om te bespreek | 1,43 | — |
Opbrengs op bates | -9,03% | — |
Opbrengs op kapitaal | -11,07% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -34,73 m | 5,97% |
Kontant van bedrywe | -32,40 m | -8,14% |
Kontant van beleggings | -31,81 m | -161,06% |
Kontant van finansiering | -3,38 m | -227,31% |
Netto kontantverandering | -66,83 m | -370,13% |
Beskikbare kontantvloei | -61,07 m | -43,54% |
Meer oor
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
HUB
Gestig
2012
Hoofkwartier
Webwerf
Werknemers
596
